Using gamification to enhance clinical trial start-up activities. Issue 1 (19th May 2022)

• Record Type: Journal Article
• Authors: Lane, Karen; Majkowski, Ryan; Gruber, Joshua; Amirault, Daniel; Hillery, Shannon; Wieber, Cortney; Thompson, Dixie D; Huvane, Jacqueline; Bridges, Jordan; Ryu, E. Paul; Eyzaguirre, Lindsay M.; Gildea, Marianne; Thompson, Richard E.; Ford, Daniel E.; Hanley, Daniel
• Is Part Of: Journal of clinical and translational science. Volume 6:Issue 1(2022)
• Publication Date: 2022-05-19
• Subjects: Gamification -- clinical trials -- metrics -- Trial Innovation Network -- trial start-up; Clinical medicine -- Research -- Periodicals; Medicine, Experimental -- Periodicals; Human experimentation in medicine -- Periodicals; 616.027
• DOI: 10.1017/cts.2022.405
• Languages: English
• ISSNs: 2059-8661

Abstract

Abstract: Background: The Trial Innovation Network (TIN) is a collaborative initiative within the National Center for Advancing Translational Science (NCATS) Clinical and Translational Science Awards (CTSA) Program. To improve and innovate the conduct of clinical trials, it is exploring the uses of gamification to better engage the trial workforce and improve the efficiencies of trial activities. The gamification structures described in this article are part of a TIN website gamification toolkit, available online to the clinical trial scientific community. Methods: The game designers used existing electronic trial platforms to gamify the tasks required to meet trial start-up timelines to create friendly competitions. Key indicators and familiar metrics were mapped to scoreboards. Webinars were organized to share and applaud trial and game performance. Results: Game scores were significantly associated with an increase in achieving start-up milestones in activation, institutional review board (IRB) submission, and IRB approval times, indicating the probability of completing site activation faster by using games. Overall game enjoyment and feelings that the game did not apply too much pressure appeared to be an important moderator of performance in one trial but had little effect on performance in a second. Conclusion: This retrospective examination of available data from gaming experiences may be a first-of-kind use in clinical trials. There are signals that gaming may accelerate performance and increase enjoyment during the start-up phase of a trial. Isolating the effect of gamification on trial outcomes will depend on a larger sampling from future trials, using well-defined, hypothesis-driven statistical analysis plans.